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Objective: Our objectives were to study delayed xenograft rejection and the
effectiveness of pretransplantation total lymphoid irradiation combined
with immunosuppression on rejection in a pig-to-baboon cardiac xenograft
model. Methods: Baboons were treated with pretransplantation total lym-
phoid irradiation, cyclosporine A (INN: ciclosporin), and methotrexate.
Orthotopic pig-to-baboon cardiac transplantations were performed after
depletion of circulating xenoreactive natural antibody by pretransplanta-
tion donor organ hemoperfusion. Tissue samples were collected for immu-
nologic and immunopathologic evaluation. Results: Pig cardiac xenografts
survived more than 18 and 19 days without evidence of hyperacute
rejection. Immunologic analysis of serum samples demonstrated that
circulating xenoreactive natural antibody levels did not return to pretrans-
plantation levels. The production of xenoreactive natural antibodies from
the recipient’s splenocytes was inhibited completely. Histologic examina-
tion of xenografts showed the feature of acute vascular rejection. Immuno-
histochemical studies demonstrated infiltration of cardiac xenografts by
large numbers of macrophages, small numbers of natural killer cells, and
a few T cells. The infiltrating macrophages also showed expression of
interleukin-1 and tumor necrosis factor. Diffuse deposition of immunoglob-
ulin G, C1Q, C3, and fibrin on xenograft vasculature was observed.
Interleukin-2 expression was not found in rejected cardiac xenografts.
Xenograft endothelial cells also showed evidence of activation (expression
of cytokines interleukin-1 and tumor necrosis factor). Conclusions: This
study demonstrates prolonged discordant cardiac xenograft survival and
delayed xenograft rejection in a pig-to-baboon model. The delayed xeno-
graft rejection is mediated by both humoral and cellular mechanisms.
Pretransplantation total lymphoid irradiation combined with cyclosporine
A and methotrexate can inhibit xenoreactive natural antibody production
but not elicited antipig antibody production and the xenoreactivity of
macrophages. (J Thorac Cardiovasc Surg 1998;115:1342-9)
Clinical cardiac allotransplantation has been lim-ited by a critical shortage of donor organs.1
Cross-species transplantation has been proposed as
an alternative to allograft transplantation. Unlike
concordant xenografts (transplantation between
closely related species), discordant xenografts
(transplantation between widely disparate species)
are usually hyperacutely rejected; the pathogenesis
of hyperacute rejection is believed to be mediated by
the binding of circulating xenoreactive natural anti-
bodies to xenograft endothelium and activation of
the classical complement pathway resulting in endo-
thelial cell injury.2
To prevent hyperacute rejection, early investiga-
tions have focused on xenoreactive natural anti-
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bodies and complement depletion using plasma ex-
change,3 donor organ hemoperfusion,4 and inhibition
of complement.5 Despite these measures, only limited
xenograft survival has been achieved. Although hyper-
acute rejection of discordant xenografts has been
overcome, the late phase of xenograft rejection,
termed delayed xenograft rejection, has become the
major barrier to the long-term xenograft survival.6
Cooper and associates4 have demonstrated severe
acute cellular rejection in one heterotopically trans-
planted heart xenograft that survived more than 5
days.4 Blakeley, Hancock, and their associates6 have
extensively evaluated the pathogenesis of delayed
xenograft rejection in a guinea pig–to–rat cardiac
xenograft model; and endothelial cell activation and
macrophages appear important in the delayed xeno-
graft rejection. In addition, Millan and coworkers7
have recently demonstrated evidence of porcine endo-
thelial cell activation in response to human macro-
phages/monocytes in an in vitro study.
In a pig-to-baboon cardiac xenotransplant model,
we8 have shown prolonged xenograft survival and
delayed xenograft rejection. Immunologic analysis
of blood samples also demonstrated increased levels
of xenoreactive natural antibodies after transplanta-
tion, suggesting that these antibodies play an impor-
tant role in delayed xenograft rejection. In the
current study, we extended our investigation to
examine the effectiveness of pretransplantation total
lymphoid irradiation (TLI) combined with immuno-
suppression in inhibiting delayed xenograft rejection
in a pig-to-baboon model of orthotopic cardiac
xenotransplantation. We have also attempted to
characterize the delayed xenograft rejection in the
orthotopic cardiac xenograft model using immuno-
histochemical staining.
Materials and methods
Animals. Three juvenile baboons, 1 to 2 years of age
and weighing 2.5 to 3.5 kg, were used as recipients.
Newborn piglets, weighing 3 to 4 kg, were used as heart
donors. Three pigs, weighing 10 kg, were used as organ
hemoperfusion donors (lung donors). All animals were
maintained with humane care in compliance with the
“Guide for the Care and Use of Laboratory Animals”
prepared by the Institute of Laboratory Animal Resources
and published by the National Institutes of Health (NIH
Publication No. 86-23, revised 1985).
Immunosuppression. Recipients were treated with 80
cGy from a 60 Co source twice a week for 5 weeks (total
800 cGy) in the Department of Radiation Medicine, Loma
Linda University Medical Center. One recipient received
an additional 400 cGy (100 cGy for 4 consecutive days) of
Fig. 1. Change of xenoreactive natural antibody levels in
recipients before and after donor organ hemoperfusion.
Fig. 2. Change of xenoreactive natural antibody levels in
recipients before and after orthotopic pig cardiac xeno-
transplantation.
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splenic irradiation after completion of TLI. Pretransplan-
tation immunosuppression consisted of intravenous meth-
otrexate twice a week (2 mg/kg) for 4 weeks and intra-
muscular cyclosporine A (INN: ciclosporin), 15 mg/kg per
day for 1 week. All recipients received perioperative
antithymocyte globulin at 15 mg/kg per day from day 3 to
4 and methylprednisolone intravenously (125 mg/day) for
3 days after orthotopic cardiac transplantation. Posttrans-
plantation immunosuppression was maintained with intra-
venous methotrexate, 2 mg/kg twice a week, and cyclo-
sporine A, 15 mg/kg per day intramuscularly. Recipients
were treated with additional intravenous methylpred-
nisolone (125 mg/day) when rejection occurred.
Depletion of xenoreactive natural antibodies and ortho-
topic cardiac transplantation. Both heart and lung do-
nors were sedated with ketamine hydrochloride (10 mg/
kg), and sedation was maintained with inhalational
halothane (0.5% to 3%) and oxygen after endotracheal
intubation. Donors were monitored by electrocardiogra-
phy. Donor hearts were exposed through a median ster-
notomy and preserved with cold cardioplegic solution
(Roe’s solution, 50 ml/kg), and donor lungs were pre-
served with 500 ml cold Collins solution containing 500 mg
aprostadil (prostaglandin E1). Both the heart and lungs
were stored in cold saline solution until donor organ
hemoperfusion and cardiac transplantation.
Anesthesia in the recipients was induced and main-
tained with inhalational fluroxane (1% to 3%) and oxy-
gen. The recipients’ hearts were exposed through a me-
dian sternotomy and removed after cardiopulmonary
bypass had been established. Donor lungs were placed in
the cardiopulmonary bypass line and the pulmonary artery
was perfused for 60 minutes with the recipients’ blood to
remove xenoreactive natural antibodies before transplan-
tation. Blood egressing from the pulmonary veins of the
lungs was returned to the bypass circuit. Blood samples
were collected before and after donor organ hemoperfu-
sion for analysis of xenoreactive natural antibodies. Pig-
to-baboon orthotopic cardiac transplantation was per-
formed according to techniques previously described.9
Packed baboon red blood cells were added to the cardio-
pulmonary bypass circuit before rewarming.
Posttransplantation monitoring. Pig cardiac xenografts
were monitored daily by two-dimensional echocardiogra-
phy. Blood samples were collected for analysis of xenore-
active natural antibodies. At the time of cessation of
xenografts, myocardial tissue was collected for histologic
and immunohistochemical analysis. Recipients’ spleens
were also harvested so that the production of xenoreactive
antibodies could be studied.
Preparation of splenocytes. Baboon spleens were col-
lected in cold (4° C) RPMI-1640 medium (Gibco Labora-
tories, Grand Island, N.Y.). The spleens were minced, and
a fine sterile steel mesh filter was used to remove the
connective tissue capsule. The cells were washed three
times with cold Hanks medium (Gibco) and then resus-
Fig. 3. Histology of xenograft from baboon TLI#1 (hematoxylin and eosin staining) demonstrating acute
infarction (asterisk) and interstitial hemorrhage (arrowheads).
Table I. Supernatant intracellular antibodies









Pig 0.0 0.0 0.092
Normal baboon #1 4390.0 955.6 0.955
Normal baboon #2 3327.5 322.2 0.870
Normal baboon #3 3923.3 63.3 1.006
Normal baboon #4 5219.2 271.1 0.831
TLI baboon #1 0.0 0.0 0.014
TLI baboon #2 0.0 291.0 0.110
TLI baboon #3 63 14 0.325
*Outer diameter 5 405 nm.
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pended in 0.83% buffered hypotonic TRIS-ammonium
chloride at 4° C to lyse red blood cells. The splenocytes
were rewashed three times with RPMI-1640 medium and
their viability was examined by trypan blue exclusion to
90%.
Pokeweed mitogen stimulation of splenocytes. Cryo-
preserved splenocytes were thawed and washed twice in
RPMI-1640 medium. The cells were then resuspended in
complete media (RPMI-1640, 20% fetal bovine serum,
glutamate 2 mmol/L, 200 IU penicillin/100 mg streptomy-
cin, pyruvate 1 mmol/L, ITS (insulin, transferrin, and
sodium selenite), and 50 mg b-mercaptoethanol) and
adjusted to a concentration of 2 3 106 cells per milliliter.
The cells were than placed in an incubator with humidi-
fied 5% carbon dioxide at 37° C and rested overnight. The
cells were harvested and resuspended at 2 3 106 cells per
milliliter in complete media containing pokeweed mitogen
500 mg/ml (Sigma, St Louis, Mo.) and then incubated for
7 days. At the end of incubation, cells were harvested,
centrifuged, and the supernatant was collected. Aliquots
were frozen and stored at –70° C.
Supernatant immunoglobulin quantification. Immu-
noglobulin levels in cell culture supernatants were deter-
mined by an enzyme-linked immunosorbent assay
(ELISA). Mouse monoclonal antibodies to either baboon
immunoglobulin M or G (IgM or IgG, PharMingen, San
Diego, Calif.) were adsorbed onto the surface of a micro-
titer plate at 4° C overnight. The plates were washed three
times with triethanolamine-buffered saline solution
(TBS), and nonspecific binding sites were blocked with
SuperBlock Blocking Buffer in TBS and then air dried.
The plates were then washed three times with TBS-Tween
followed by the addition of standards and cell culture
supernatants to the appropriate wells. After 2 hours’
incubation, the plates were washed three times with
TBS-Tween solution and the appropriate secondary anti-
bodies were added (alkaline phosphatase–labeled mono-
clonal mouse antihuman IgM, PharMingen, San Diego,
Calif., and IgG, Fisher, Pittsburgh, Pa.). The plates were
incubated at room temperature for 2 hours. After a final
wash with TBS-Tween solution, the substrate was added.
The absorbance of each well was measured at 405 nm
within 1 hour.
Measurement of xenoreactive natural antibodies in the
serum and supernatant. The supernatant and serum lev-
els of xenoreactive natural antibodies were measured by
an ELISA using the method described by Kujundzic and
associates.10 Gal antigens-aGal(1-3)bGal(1-4)GlcNac-
BSA (V-LABS, Inc., Covington, La.) were adsorbed onto
the surface of a microtiter plate at 4° C for 17 hours. The
plates were washed three times with TBS, and nonspecific
binding sites were blocked with SuperBlock Blocking
Buffer in TBS. Immediately before the assay, the plates
were washed three times with TBS-Tween solution. Cell
culture supernatants from pokeweed mitogen–stimulated
splenocytes and serum samples were added to the wells
and incubated for 2 hours at room temperature. The
plates were washed four times with TBS-Tween solution
followed by addition of the secondary antibody (alkaline
phosphatase–labeled antihuman IgM and IgG, Fisher,
Pittsburgh, Pa.). After 2 hours of incubation at room
temperature, the plates were rewashed four times with
TBS-Tween solution. Substrate was added to the wells and
after 1 hour the absorbance of each well was measured at
405 nm.
Histology and immunohistology. Biopsy specimens of
the cardiac xenografts were collected and fixed in 10%
neutral-buffered formalin. Standard paraffin sections were
prepared and stained with routine hematoxylin and eosin
stain and examined microscopically. Small pieces of car-
diac xenografts were snap-frozen in ornithine carbamyl-
transferase (OCT) medium and then stored at –70° C until
immunohistologic analysis. After cryostat sections were
fixed with paraformaldehyde-lysineperiodate, tissue sec-
Fig. 4. Photomicrograph of xenograft from baboon TLI#2 demonstrating microvascular thrombosis
(some marked with asterisks).
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tions were than stained with antibodies to IgM, IgG, C1q,
C3, and fibrin to determine humoral rejection; monoclo-
nal antibodies to macrophages, T cells, B cells, to identify
the types of infiltrating baboon leukocytes; and an anti-
body to the cytokine IL-1 and IL-2, tumor necrosis factor
(TNF-a), as previously described.6
Results
Xenograft survival and natural antibody titers.
Two recipients (TLI#1 and TLI#2) fully recovered
from orthotopic cardiac transplantation without
technical failure, and all xenografts functioned well
without any evidence of hyperacute rejection. One
recipient (TLI#3) died 3 hours after transplantation
because of multiple arrhythmias and hemodynamic
instability but lacked evidence of immediate hyper-
acute rejection. Pig cardiac xenograft survival times
were 18 and 19 days before death.
Serum levels of xenoreactive natural antibodies
were reduced significantly after pretransplantation
donor organ hemoperfusion without returning to
pretransplantation levels (Fig. 1). Very low levels of
xenoreactive natural antibodies in serum samples
obtained after transplantation were observed; this
low level was maintained until the recipients died
(Fig. 2).
Xenoreactive natural antibody production and
release from baboon splenocytes. Table I summa-
rizes production and release of intracellular anti-
bodies from baboon splenocytes. As positive con-
trols, normal baboon splenocytes released very high
levels of IgM and IgG antibodies. ELISA demon-
strated that these intracellular antibodies directly
recognized and bound to pig xenoantigens at very
high levels. In contrast, the recipients’ splenocytes
failed to produce and release high levels of antibod-
ies including xenoreactive natural antibodies. Only
one recipient showed IgG antibody formation. The
binding levels of xenoreactive natural antibodies to
pig xenoantigens remained very low.
Immunopathology of xenografts. At the time of
cessation of cardiac xenografts, gross appearance of
xenografts included swollen, thickened cardiac walls
and hemorrhage. Histologic study revealed evidence
of acute vascular rejection, which included intersti-
tial edema and hemorrhage, microvascular throm-
bosis, and acute infarction (Figs. 3 and 4).
Immunohistochemical staining of rejected xeno-
grafts demonstrated deposition of baboon IgM, IgG,
C1q, C3, and fibrin on the surface of xenograft
endothelial cells, suggesting humoral rejection (Fig.
5). The infiltrate of cardiac xenografts consisted of
large numbers of macrophages and smaller numbers
of natural killer (NK) cells (10% to 20%). Very few
T cells were seen in xenografts (Fig. 6). The infil-
trating macrophages showed expression of IL-1b
and TNF-a, and the expression of IL- 1b and TNF-a
Fig. 5. Immunopathologic studies of rejected pig hearts from baboons showed diffuse endothelial
membrane staining for IgG (left, arrows) and complement C3 (right, arrows).
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on xenograft endothelial cells and myocardial areas
was observed in close relationship to macrophage
infiltration (Fig. 7). The expression of IL-2 on
infiltrating T cells and xenografts was not identified
(data not shown).
Discussion
Hyperacute rejection mediated by the recipient’s
circulating xenoreactive natural antibodies and com-
plement has been considered as the first major
barrier to successful discordant cardiac xenograft-
ing. Previous studies have shown that depletion of
xenoreactive natural antibodies and complement
can prevent hyperacute rejection and results in
limited prolongation of xenograft survival.3-5, 8 In
this study, we were able not only to deplete baboon
circulating xenoreactive natural antibodies but also
inhibit their production using pretransplantation
TLI and immunosuppression resulting in 18 and 19
days’ survival of orthotopic xenografts. TLI has been
used as immunosuppressive therapy or tolerance
induction therapy in both allograft11, 12 and concor-
dant xenograft transplantation13, 14 and has been
shown to be effective in inhibiting antidonor anti-
body production and cell-mediated responses.
Increasing evidence suggests that discordant
xenograft rejection (after overcoming hyperacute
rejection) is associated with increased synthesis of
xenoreactive natural antibodies. A previous study by
us has shown that posttransplantation production of
xenoreactive natural antibodies corresponded with
xenograft rejection in a pig-to-baboon cardiac xeno-
graft model receiving immunosuppressive therapy of
cyclosporine A and 15-deoxyspergualin.15 In a pig-
to-human liver perfusion study, Cotterell and asso-
ciates16 demonstrated an increase in concentration
of xenoreactive natural antibodies that directly rec-
ognized pig xenoantigens. The present study pro-
vides important information regarding the immuno-
suppressive effectiveness of TLI combined with
immunosuppression of cyclosporine A and metho-
trexate on the production of xenoreactive natural
antibodies in a discordant xenograft model. We have
demonstrated low levels of circulating xenoreactive
natural antibodies in all recipients after xenotrans-
plantation and the inhibition of xenoreactive natural
antibody production from the recipient’s spleno-
cytes. We assume that this treatment protocol di-
rectly suppresses B cell activity, particularly on B
cells that produce xenoreactive natural antibodies.
In contrast, this combined therapy failed to block
the production of elicited antidonor antibodies that
were detected by immunohistochemical staining
showing the deposition of antibody and complement
on xenografts. We speculate that the mechanism of
elicited antidonor antibody production is a T cell–
independent B cell response, since we did not
demonstrate the presence of T cells in the xeno-
grafts and expression of IL-2.
It has been widely believed that the recipient’s
Fig. 6. Immunopathologic studies of rejected pig hearts from baboons showed positive staining for few
T-cell infiltrates (left, arrows) and large numbers of macrophages (right).
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immune system will recognize and respond to xeno-
grafts once hyperacute rejection is overcome, result-
ing in so-called delayed xenograft rejection. The
present study demonstrates the pathogenic mecha-
nisms of delayed xenograft rejection in an ortho-
topic pig-to-baboon cardiac xenograft model. This
study has found evidence of both humoral and
cellular rejection mechanisms in xenografts under-
going delayed xenograft rejection, including deposi-
tion of antibody and complement and cellular infil-
tration. Unlike allografts or concordant xenografts,
the majority of infiltrating lymphoid cells were mac-
rophages, 10% to 20% NK cells, but very small
numbers of T cells, suggesting that macrophages/NK
cells play an important role in delayed xenograft
rejection. Blakeley, Hancock, and their associates6
showed progressive infiltration of macrophages in a
guinea pig–to–rat cardiac xenograft model that was
treated with cobra venom factor. However, this
guinea pig–to–rat model did not demonstrate hu-
moral rejection resulting from the complement de-
pletion by cobra venom factor.6 Candinas and co-
workers17 demonstrated that macrophages/NK cell–
mediated delayed xenograft rejection is not altered
by the presence or absence of T cells. In an in vitro
study, Vallee and colleagues18 have shown de-
creased lymphocyte proliferation in response to pig
endothelial cells after depletion of macrophaged
monocytes. In our study, although a small number of
T cells were present in xenografts, there was a lack
of IL-2 expression on xenografts. This evidence
suggests that T cells do not play an important role in
the early phase of delayed xenograft rejection in
discordant xenografts.
In this study, pig xenografts undergoing delayed
rejection demonstrated evidence of xenograft vascu-
lar endothelial activation and activated macro-
phages/NK cells. The expression of IL-1, TNF-a,
and E-selectin was observed and could be associated
with macrophage xenoreactivity. A previous study
showed type II endothelial cell activation in delayed
xenograft rejection, including expression of P-selec-
tin, E-selectin, and von Willebrand factor. The
expression of selectin is associated with production
of interferon, TNF-a, IL-1, and other cytokines.6
Furthermore, in a recent in vitro study, Millan and
coworkers7 demonstrated that direct contact of
monocytes/macrophages and porcine endothelial
cells can induce E-selectin expression on porcine
endothelial cells, and human IL-1 a induces expres-
sion of E-selectin on endothelial cells. These find-
ings suggest that activation of macrophages/NK cells
and xenograft vascular endothelial cells play an
important role in delayed xenograft rejection of
discordant xenotransplantation.
As an alternative to clinical allotransplantation,
Fig. 7. Immunopathologic studies of rejected pig hearts from baboons showed expression of TNF-a (left)
and IL-1b (right) by infiltrating macrophages. TNF-a staining includes the area surrounding macrophages,
as well as adjacent endothelial cells and focal myocardial areas. IL-1b was observed in close relationship
to macrophages, plus locally on the surfaces of endothelial cells (arrows).
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the application of discordant cardiac xenografts to
human beings is still limited by delayed xenograft
rejection. However, consistent 21⁄2 weeks’ orthotopic
discordant cardiac xenograft survival can be
achieved using TLI and novel but conventional
immunosuppression in this pig-to-baboon model.
This study demonstrates that induced antipig (rath-
er than naturally occurring) antibody production
and macrophages/NK cells are responsible for the
delayed xenograft rejection. This information fur-
ther strengthens our hypothesis that pig-to-human
heart xenotransplantation may eventually be feasi-
ble when activation of xenograft endothelial cells
and delayed xenograft rejection can be overcome.
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